Kura Oncology, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
COGT
Cogent Biosciences, Inc. |
$8.06 | $802.20 M | -3.37 | 205 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
KALV
KalVista Pharmaceuticals, Inc. |
$8.68 | $492.76 M | -3.74 | 150 | $0 |
KNSA
Kiniksa Pharmaceuticals, Ltd. |
$20.02 | $1.35 B | 146.62 | 315 | $423.24 M |
LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
VRDN
Viridian Therapeutics, Inc. |
$20.07 | $776.72 M | -2.71 | 143 | $302,000 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
